A detailed history of Twin Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Twin Capital Management Inc holds 61,198 shares of MRK stock, worth $5.96 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
61,198
Previous 62,246 1.68%
Holding current value
$5.96 Million
Previous $7.71 Million 9.82%
% of portfolio
0.81%
Previous 0.93%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $116,485 - $135,160
-1,048 Reduced 1.68%
61,198 $6.95 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $116,124 - $124,716
938 Added 1.53%
62,246 $7.71 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $978,393 - $1.14 Million
8,640 Added 16.4%
61,308 $8.09 Million
Q4 2023

Jan 31, 2024

BUY
$100.18 - $109.02 $182,327 - $198,416
1,820 Added 3.58%
52,668 $5.74 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $2.7 Million - $3 Million
-26,213 Reduced 34.02%
50,848 $5.23 Million
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $356,023 - $388,049
3,278 Added 4.44%
77,061 $8.89 Million
Q1 2023

May 08, 2023

SELL
$102.94 - $114.86 $845,240 - $943,115
-8,211 Reduced 10.01%
73,783 $7.85 Million
Q4 2022

Jan 31, 2023

SELL
$87.44 - $112.11 $150,484 - $192,941
-1,721 Reduced 2.06%
81,994 $9.1 Million
Q3 2022

Oct 21, 2022

BUY
$84.53 - $94.96 $237,613 - $266,932
2,811 Added 3.47%
83,715 $7.21 Million
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $329,535 - $373,544
3,947 Added 5.13%
80,904 $7.38 Million
Q1 2022

May 06, 2022

BUY
$73.51 - $82.4 $345,129 - $386,868
4,695 Added 6.5%
76,957 $6.31 Million
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $423,922 - $531,017
5,865 Added 8.83%
72,262 $5.54 Million
Q3 2021

Oct 29, 2021

SELL
$71.68 - $78.83 $3.03 Million - $3.33 Million
-42,234 Reduced 38.88%
66,397 $4.99 Million
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $976,816 - $1.08 Million
-13,893 Reduced 11.34%
108,631 $8.45 Million
Q1 2021

May 06, 2021

SELL
$68.86 - $81.11 $1.5 Million - $1.77 Million
-21,790 Reduced 15.1%
122,524 $9.45 Million
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $441,600 - $490,086
-6,153 Reduced 4.09%
144,314 $11.8 Million
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $234,029 - $265,274
-3,198 Reduced 2.08%
150,467 $12.5 Million
Q2 2020

Aug 04, 2020

SELL
$70.42 - $80.13 $594,696 - $676,697
-8,445 Reduced 5.21%
153,665 $11.9 Million
Q1 2020

Apr 29, 2020

BUY
$63.36 - $87.82 $462,021 - $640,383
7,292 Added 4.71%
162,110 $12.5 Million
Q4 2019

Jan 29, 2020

SELL
$77.58 - $87.54 $2.96 Million - $3.34 Million
-38,110 Reduced 19.75%
154,818 $14.1 Million
Q3 2019

Oct 28, 2019

SELL
$76.08 - $82.93 $328,133 - $357,677
-4,313 Reduced 2.19%
192,928 $16.2 Million
Q2 2019

Aug 01, 2019

SELL
$69.84 - $81.59 $5.59 Million - $6.53 Million
-80,032 Reduced 28.86%
197,241 $16.5 Million
Q1 2019

May 03, 2019

BUY
$69.58 - $79.36 $183,691 - $209,510
2,640 Added 0.96%
277,273 $23.1 Million
Q4 2018

Feb 04, 2019

SELL
$65.24 - $75.71 $204,853 - $237,729
-3,140 Reduced 1.13%
274,633 $21 Million
Q3 2018

Nov 08, 2018

BUY
$57.69 - $67.84 $452,462 - $532,069
7,843 Added 2.91%
277,773 $19.7 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $39,647 - $46,581
780 Added 0.29%
269,930 $16.4 Million
Q1 2018

May 01, 2018

BUY
$50.96 - $59.23 $331,240 - $384,995
6,500 Added 2.47%
269,150 $14.7 Million
Q4 2017

Jan 29, 2018

BUY
$51.62 - $61.64 $247,776 - $295,872
4,800 Added 1.86%
262,650 $14.8 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $631,289 - $679,278
10,760 Added 4.35%
257,850 $16.5 Million
Q2 2017

Aug 07, 2017

BUY
N/A
247,090
247,090 $15.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.